Clinical Trial Update: BMB-101 in Absence Epilepsy and DEE [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for BMB-101 in absence epilepsy and developmental and epileptic encephalopathies, including Jeavons syndrome, Dravet syndrome, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Absence Epilepsy
• Dravet Syndrome
• Jeavons Syndrome
• Lennox-gastaut Syndrome

Drugs mentioned

• BMB-101

Snippet

Sponsor: Bright Minds Biosciences Pty Ltd | Conditions: Absence Epilepsy, Jeavons Syndrome | Phase 2 | Status: RECRUITING